In a model of breast cancer, for example, it was revealed that reducing PGE2 expression via deletion of cyclooxygenase-2 (COX-2) in TAMs could enhance T cell survival and immune surveillance and thereby suppress mammary tumor progression (81). This evidence concerns the gene PTGS2 and breast cancer.